ArcelorMittal Liberia (AML), in partnership with the Government of Liberia, has announced the launch of the 10th batch of its ...
Get the latest on Curis, Inc.’s Q3 2025 earnings, clinical trial milestones, and investment outlook in rare lymphoma and CLL.
Health Enterprises Network (HEN) and Advanced Manufacturing and Logistics Network (AML) celebrated the graduation of 26 ...
Former Binance CEO Changpeng Zhao on Friday denied having any business ties with President Trump or his sons, adding that he ...
2don MSN
Leaked letters reveal Elizabeth Warren’s response to Binance founder’s defamation threat
Leaked letters posted on X reveal BakerHostetler accused Sen. Elizabeth Warren of defaming Binance founder Changpeng Zhao ...
Two Presentations at ASH 2025 to highlight preclinical data and clinical development plans for GB3226, a novel dual ENL-YEATS and FLT3 inhibitor ...
M2T-CD33 (LTI-214) has received FDA orphan drug designation, offering incentives like tax credits and market exclusivity for AML treatment. The treatment targets CD33, a glycoprotein present in 90% of ...
Vivesto AB ( ($SE:VIVE) ) just unveiled an update. Vivesto AB announced positive preclinical results for Cantrixil in combination with standard ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to M2T-CD33 (LTI-214) for the treatment of ...
Q3 2025 Earnings Call Transcript November 4, 2025 Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1 ...
Promising Phase 1 clinical data for CLN-049, a FLT3xCD3 bispecific T cell engager, demonstrating ~30% CRc rate in heavily pretreated, all-comer population of patients with relapsed/refractory AML to b ...
Overview: Countries like the UAE, Japan, and the US have made crypto licensing expensive to ensure stronger investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback